Amy Sullivan - Aug 9, 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Financial Officer
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
Stock symbol
IOBT
Transactions as of
Aug 9, 2023
Transactions value $
$99,999
Form type
4
Date filed
8/9/2023, 08:41 PM
Previous filing
Mar 22, 2023
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOBT Common Stock Award $93.8K +49.4K +197.53% $1.90 74.4K Aug 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Warrants (Right to Buy) Award $6.17K +49.4K $0.13* 49.4K Aug 9, 2023 Common Stock 49.4K $2.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023.